Predicta Biosciences Completes $23.4 Million Series A Financing Round

Wilson Sonsini Goodrich & Rosati has advised Predicta Biosciences.Predicta Biosciences, a precision oncology company focused on developing novel diagnostic and therapeutic discovery solutions, has announced the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here